Matches in Nanopublications for { ?s ?p "[We now show, using a large cohort of mastocytosis patients, including an almost equal number of aggressive and nonaggressive cases of systemic mastocytosis, that in contrast to the oncogenic KITD816V, TET2 mutation statistically associates with aggressive forms of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP616241.RAbEC7GoeJMYEPVMEsd9bLNP5yFZW4thT7yCx0g58MqnQ130_assertion description "[We now show, using a large cohort of mastocytosis patients, including an almost equal number of aggressive and nonaggressive cases of systemic mastocytosis, that in contrast to the oncogenic KITD816V, TET2 mutation statistically associates with aggressive forms of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616241.RAbEC7GoeJMYEPVMEsd9bLNP5yFZW4thT7yCx0g58MqnQ130_provenance.
- NP914117.RAwQGFKzfECgXidlpdiY13hXcIj2MSDiu14VXYo-sfWj0130_assertion description "[We now show, using a large cohort of mastocytosis patients, including an almost equal number of aggressive and nonaggressive cases of systemic mastocytosis, that in contrast to the oncogenic KITD816V, TET2 mutation statistically associates with aggressive forms of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914117.RAwQGFKzfECgXidlpdiY13hXcIj2MSDiu14VXYo-sfWj0130_provenance.
- assertion description "[We now show, using a large cohort of mastocytosis patients, including an almost equal number of aggressive and nonaggressive cases of systemic mastocytosis, that in contrast to the oncogenic KITD816V, TET2 mutation statistically associates with aggressive forms of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1021783.RAiK5AFNAaTpfqYinTWkWC7OxtfRGgxNfmV-qTywXEENE130_assertion description "[We now show, using a large cohort of mastocytosis patients, including an almost equal number of aggressive and nonaggressive cases of systemic mastocytosis, that in contrast to the oncogenic KITD816V, TET2 mutation statistically associates with aggressive forms of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1021783.RAiK5AFNAaTpfqYinTWkWC7OxtfRGgxNfmV-qTywXEENE130_provenance.